Pro-ficiency Appoints Jenna Rouse As VP of Client Success

December 1, 2020/273 Comments/in News/by Collin Brooks

PRO-FICIENCY APPOINTS JENNA ROUSE AS VP OF CLIENT SUCCESS
This year’s most exciting news! Jenna Rouse has joined the team at Pro-ficiency as the VP of Client Success.

Durham, NC — December 1, 2020

Jenna Rouse has been turning heads and lighting up minds in the training industry since she joined the Association for Clinical Research Professionals (ACRP) 16 years ago. Her expertise in building partnerships and new business opportunities for ACRP quickly led to her development of a strong understanding of the training gaps and needs among CROs, Sponsors and sites within the clinical research enterprise. Her move to Pro-ficiency is a testament to the growth and exciting future of our organization.

“Our company has grown to where it became clear we needed to expand our team to ensure continued outstanding customer support and innovative solutions. I have known Jenna professionally for several years, and when the opportunity arose to bring her onto the Pro-ficiency team, we knew it was a win for the organization, and for our valued clients” –JoAnne Schaberick, Co-CEO at Pro-ficiency.

“I loved working with Pro-ficiency as their client” says Rouse. “The Pro-ficiency platform and simulation programs are truly ground-breaking in the clinical research space and I knew I needed to be a part of a company with that kind of vision”.

Jenna will work with the Executive Sales Team to manage mature, existing and new business accounts, and generate additional business opportunities within that client base. Her attention to high standards and superior client relationships is sure to add to our continual success.

About Pro-ficiency

Pro-ficiency utilizes simulation-training, eMentoring, and analytics to train researchers to the highest performance standards possible. Leading the virtual revolution in remote site support, we provide remote site training, compliance and communication tools to 60,000+ clinical researchers globally. Our virtual toolkit helps study teams meet the challenge of training and communicating with sites.

Initiate trial sites faster and more efficiently and reduce protocol violations with our easy-to-use web-based platform. Learn more at proficiency3.wpengine.com.

Source: Pro-ficiency LLC

TissueTech Announces Engagement of Pro-ficiency Virtual Study Trainer™ for Clinical Trials

November 19, 2020/in News/by Collin Brooks

FOR IMMEDIATE RELEASE

For More Information, Contact:
Barbara Getz
305-370-5708
bgetz@tissuetechinc.com

TissueTech Announces Engagement of Pro-ficiency Virtual Study Trainer™ for Clinical Trials

Miami, FL – November 19, 2020 – TissueTech, Inc., an emerging biotechnology company and pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today the engagement of Pro-ficiency Virtual Study Trainer™ to facilitate remote study protocol training for TissueTech’s clinical trial investigators and their clinical research teams.

TissueTech has been quick to integrate proven technologies to meet the rapidly changing clinical trial industry landscape during the pandemic and maintain compliance with FDA guidance. Even in the best of times, effectual training on complicated protocols is a challenge. Ensuring investigator compliance with regulatory guidelines is paramount to building a foundation for any successful trial. Recognizing the costs and risks associated with face-to-face training and needing a proven solution, TissueTech selected Pro-ficiency to ensure success in their late-breaking Diabetic Foot Ulcer study in this new operating environment.

“As we were evaluating ways to leverage innovative technologies to solve some of the challenges faced with launching late-breaking trials amidst the onset of the pandemic, investigator training was a specific area of focus and concern,” said Tommy Lee, Vice President of Clinical Operations at Tissue Tech. “Pro-ficiency uniquely stood out from the available options providing critical measures of protocol understanding through simulation training. This method was very attractive as it optimized the investigator’s ability to learn through immersive and engaging real-world scenarios designed to test their understanding of the trial’s protocol.”

Pro-ficiency’s Virtual Study Trainer ™ uses the most advanced Remote Site Performance Management technology in the industry. Offering both Virtual IM™ and Virtual SIV™, Pro-ficiency aids in avoiding the cost and complexity of travel and scheduling and training every investigator and site staff to the highest performance standards possible. Remote learning at Pro-ficiency utilizes simulation-training and remote site performance management, ensuring virtual training is just as effective as the face-to-face alternative.

Pro-ficiency CEO David Hadden says: “We are proud to be working alongside TissueTech on a meaningful, innovative project targeting an unmet medical need in diabetic patients living with complex diabetic foot ulcers and in need of advanced wound management.”

About TissueTech, Inc.

TissueTech, Inc., the parent company of Amniox Medical, Inc. and Bio-Tissue, Inc., is a scientific and market leader in the field of regenerative medicine. TissueTech manufactures a broad range of ocular, surgical, wound care, and soft tissue products that are marketed under these subsidiaries. Since the company’s inception, clinicians have performed more than 500,000 human implants of the company’s products and published more than 360 peer-reviewed studies supporting its platform technology. TissueTech is committed to an unwavering culture of integrity that places our patients’ safety and clinical outcomes above all else. Learn more at https://tissuetech.com/.

Pro-ficiency and Scarritt Group Join Forces

August 18, 2020/619 Comments/in News/by Collin Brooks

Pro-ficiency and Scarritt Group Join Forces to Create Comprehensive Solutions for Virtual Investigator Meetings and Site Initiation Visits

DURHAM, N.C., August 18, 2020 (Newswire.com) – Pro-ficiency and Scarritt Group Inc. are pleased to announce that they have entered into a global strategic partnership, combining Pro-ficiency’s unique simulation-based trial training technology with Scarritt Group’s Virtual Conference Center to offer a comprehensive solution for Virtual Investigator Meetings and Site Initiation Visits.

“Since the pandemic, pharmaceutical sponsors have been struggling to replace traditional face-to-face investigator meetings with a virtual solution. To do this effectively, you need to carefully consider all the objectives of an IM and what blend of technology does the best job with each of those objectives,” said Pro-ficiency co-CEO Dave Hadden. “There are three main objectives of an IM: train your investigators, meet them to develop a solid working relationship with them, and build interest and excitement about your study. Virtual-IM™ provides a best-in-class offer that satisfies those three objectives.”

After the training and investigator meeting is conducted, Scarritt and Pro-ficiency offer Virtual-SIV™ which manages all site onboarding activities such as staff training and site inspection.

The combined Scarritt and Pro-ficiency solution offers the best-in-class approach for each of these objectives. Pro-ficiency’s Virtual Study Trainer uses advanced simulation training technology to assess and train investigators to the maximum performance levels possible, and all online and asynchronously. “When the investigator comes to Scarritt’s Virtual Conference Center for the live component of the meeting, we already know their strengths and knowledge gaps so the study teams can focus the meeting agenda on the areas with the highest risk,” commented Adrienne Williams, Scarritt CEO. “Engaging investigators online is hard when you lose the face-to-face component. Our VCC facilitates face-to-face interactions between investigators and study team members to develop those connections. We also use proprietary AI-avatars and live conference facilitators to keep the investigators interested and engaged in the meeting.”

Scarritt and Pro-ficiency have been utilizing these virtual products for over five years. This is not new to them and they have had time to perfect the approach. Together, the companies have conducted over 2,000 virtual investigator meetings and provided virtual study training to over 120,000 investigators.

About Scarritt Group

Scarritt Group is an international meeting planning and logistics company that focuses on providing clinical meetings. Scarritt Group was founded in 1999 and has substantial knowledge in meeting planning for many different industries. Learn more at scarrittgroup.com.

About Pro-ficiency

Pro-ficiency is a comprehensive human performance improvement system for clinical trials. Initiate trial sites faster and more efficiently and reduce protocol violations with our easy-to-use web-based platform. Learn more at proficiency3.wpengine.com.

Source: Pro-ficiency LLC

ACRP – Pro-ficiency Partnership

February 11, 2020/in News/by Collin Brooks

FOR IMMEDIATE RELEASE: February 11, 2020

CONTACT:
Jeremy Glunt
+ 1.703.258.3506
media@acrpnet.org

ACRP, Pro-ficiency Partnership Signals New Era in Clinical Research Workforce Competency Development

Washington, DC – Clinical research workforce development is taking a major step into the future thanks to a partnership announced today by the Association of Clinical Research Professionals (ACRP) and Pro-ficiency.

The new partnership brings together two of the world’s leading providers of clinical research workforce development solutions, and will empower ACRP to provide a next-generation, competence-based professional development experience to its global network of 50,000-plus clinical research professionals and organizations.

“Despite the important role clinical trials play in the development of new drugs and therapies, our industry has too often and for too long approached workforce development with a ‘check box’ mentality—ensuring compliance with training requirements, but failing to adequately develop competency or raise the standard of clinical trial conduct,” says Jim Kremidas, ACRP Executive Director. “By connecting clinical research professionals and organizations with cutting-edge development programs, this partnership will usher in a new era in workforce development that will fully unlock the potential of our profession.”

The partnership pairs ACRP’s industry-leading training and development programs with Pro-ficiency’s revolutionary compliance management system that reveals key insights into team competency.

“Organizations who partner with ACRP will now have actionable data they can use to assess team competency and to make informed decisions about staff development activities with a rigorous focus on mitigating risk and addressing performance gaps,” Kremidas says.

The Pro-ficiency compliance management system removes the mystery and challenges of staff development. With a user-friendly interface, training administrators can easily manage users, assign and track completion of development programs, and access certificates of completion required for regulatory and protocol compliance. User-specific data provided for each development program provides administrators and leadership with valuable insights into areas for additional training and risk mitigation activities.

ACRP and Pro-ficiency will also collaborate in developing ACRP’s portfolio of competency-based simulation modules that will enable clinical trial staff to master key skills.

“Experiential learning, or learning by doing, is the most effective way to train teams on critical processes and skills. Simulation-based training personalizes the learner experience, improving knowledge acquisition and increasing retention of key learnings,” says JoAnne Schaberick, Co-CEO of Pro-ficiency.

“By leveraging Pro-ficiency’s proven expertise developing practical, application-based learning programs that employ effective, simulation-based training methodologies, ACRP is reinventing traditional online learning in the clinical research enterprise with a focus on true competency development,” Kremidas adds.

ACRP and Pro-ficiency will showcase the power of this new partnership at the 2020 SCOPE conference in Orlando, Florida, February 18-21.

About ACRP

In clinical research, people are everything. ACRP raises clinical research standards and accelerates careers. Better people. Better results. www.acrpnet.org

About Pro-ficiency

Pro-ficiency is a comprehensive human performance improvement system for clinical trials. Initiate trial sites faster and more efficiently and reduce protocol violations with our easy-to-use web-based platform. Learn more at proficiency3.wpengine.com.

Pro-ficiency Wins the Start-Up Component of VCIC – Venture Capital Investment Competition

April 5, 2019/1 Comment/in News/by Collin Brooks

DURHAM, N.C., April 5, 2019 (Newswire.com) – Pro-ficiency, a start-up company providing a comprehensive human performance improvement system for clinical trials, has won the Venture Capital Investment Competition (VCIC) at the UNC Kenan-Flagler School of Business for the second time. The VCIC is the leading venture capital competition for business students and has been running for 21 years. The program serves 1,500 students, 150 venture capitalists and 100 entrepreneurs worldwide. Universities from around the United States and Canada sponsor student teams to compete in regional competitions, and the seven finalists compete at UNC for the championship. This year’s finalists were Acadia University, Brigham Young University, Cornell, Georgetown, Miami University, Notre Dame and Utah Valley University.

VCIC seeks to raise college students’ awareness of the venture capital process by pairing entrepreneurs with exceptional students acting as venture capitalists. Companies pitch their business ideas to a team of students. Then students select which business they want to fund. A panel of judges comprised of expert venture capitalists pick a winning team based on the quality of their due diligence and their final investment offering or “Term Sheet.” This year, BYU took home the top prize and second and third were awarded to Utah Valley and Miami University.

Pro-ficiency received five of the seven terms sheets, making it the winner of the start-up side of the competition. Dave Hadden, CEO of Pro-ficiency, says this about the program: “I love participating in this competition. I am passionate about entrepreneurship, and these outstanding students will lead many start-ups of the very near future.” Patrick Vernon, Clinical Associate Professor of Strategy and Entrepreneurship at UNC Kenan-Flagler and Director of VCIC, commented, “Dave Hadden participated in 2013 with TheraSim, and received the most terms sheets that year also. TheraSim subsequently sold to WebMD in 2014, so our students must be onto something. It is passionate, successful founders like Dave that make VCIC such a valuable learning experience.”

About Pro-ficiency

Pro-ficiency leverages simulation to provide real-world training experiences for clinical trials. Pharmaceutical Sponsors use Pro-ficiency to initiate trial sites faster and more efficiently and to
identify possible protocol deviations. With the help of Pro-ficiency, Sponsors decrease study time, lower costs, conduct early protocol feasibility, reduce patient safety risk and predict and avoid study errors.

For more information, contact:
Natalie Rosen, Public Relations Manager, (919) 245-7870, info@pro-ficiency.com
Source: Pro-ficiency LLC

Additional Links

https://vimeo.com/254765818 – Message from Pro-ficiency CEO

About Pro-ficiency

Pro-ficiency is a simulation company focused on improving human performance in clinical trials, and
providing better education tools for patients and healthcare providers.
https://proficiency.wpengine.com | Media Room

Company Address

44 Court St. Suite 1217
Brooklyn, NY 11201

Pro-ficiency and Scarritt Group Join Forces to Create Comprehensive Solutions for Virtual Investigator Meetings and Site Initiation Visits

About Pro-ficiency

About Pro-ficiency

Additional Links

Related Video

About Pro-ficiency

Company Address